External organizationCovance Inc.

Basic data

Name:

Covance Inc.

Country:

United States

Region/province:

New Jersey

City:

Princeton

URL:

de.covance.com

Projects

KEYNOTE 054 – Adjuvant immunotherapy with anti-PD-1 monoclonal antibody Pembrolizumab (MK-3475) versus placebo after complete resection of high-risk Stage III melanoma: A randomized, double-blind Phase 3 trial of the EORTC Melanoma Group.

2016 - 2020

Covance Inc.

Help

will be deleted permanently. This cannot be undone.